Perioperative machine learning models with SHAP interpretation for predicting adverse outcomes in breast cancer surgery.

Objective: To investigate the clinical value of a machine learning model constructed using perioperative data for predicting adverse postoperative outcomes in patients undergoing breast cancer surgery, and to identify key decision factors through SHAP interpretability analysis. Methods: Perioperative core indicators and follow-up data from 643 treatment-naïve patients with breast cancer who underwent surgical treatment were retrospectively collected, including 443 cases in the modeling set and 200 cases in the external validation set, derived from two independent medical centers. The modeling set was stratified and split into training and internal validation sets in 7:3 ratio. After screening key variables using univariate analysis in the training set, five predictive models for postoperative adverse prognosis were developed based on Extreme Gradient Boosting (XGBoost), Random Forest (RF), Gradient Boosting Machine (GBM), Support Vector Machine (SVM), and Logistic Regression (LR) algorithms. The model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves (CC), and decision curve analysis (DCA) in both the internal and external validation sets, and the feature contributions of the optimal model were interpreted using the Shapley Additive exPlanations (SHAP) method. Results: The predictive model for postoperative adverse prognosis constructed using the XGBoost algorithm demonstrated optimal performance, showing strong discriminatory ability in both the internal (AUC = 0.840) and external (AUC = 0.780) validation sets. In the external validation set, its specificity (0.881) and F1 score (0.514) were higher than those of the other models. In addition, calibration analysis indicated good agreement between the predicted probabilities and actual incidence rates for the XGBoost model, and decision curve analysis demonstrated that it provided the highest clinical net benefit across most threshold ranges. SHAP analysis revealed that the top three variables contributing the most to the XGBoost model's prediction of postoperative adverse prognosis were the systemic immune-inflammation index (SII), prognostic nutritional index (PNI), and age, in descending order. Conclusion: The XGBoost model constructed using perioperative data can effectively predict adverse postoperative outcomes in patients with breast cancer undergoing surgery, outperforming traditional models and other machine learning approaches. The preoperative SII level is the most critical predictive factor.